This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Children's Medical Center Corporation. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
**Title: Innovator Rajeev Sivasankaran: Pioneering Axon Regeneration Research**
Introduction
Rajeev Sivasankaran, based in Boston, MA, is an accomplished inventor with a notable focus on the field of regenerative medicine. With two patents to his name, he is dedicated to advancing our understanding of central nervous system neuron axon regeneration.
Latest Patents
Sivasankaran’s latest contributions to the field involve innovative approaches to axon regeneration, particularly through the use of Protein Kinase C (PKC) inhibitors. His patents detail a method for promoting regenerative growth of an adult mammalian central nervous system neuron axon, which is often hindered by endogenous growth repulsion factors found in myelin. By delivering a therapeutically effective amount of a specific PKC inhibitor directly to the axon, Sivasankaran's invention opens new avenues for enhancing axonal regenerative growth and detection.
Career Highlights
Currently, Rajeev Sivasankaran is affiliated with the Children’s Medical Center Corporation, where he continues to push the boundaries of research in neurobiology and regenerative therapies. His work is characterized by a commitment to translating scientific discoveries into practical solutions for neurological injuries.
Collaborations
Throughout his career, Sivasankaran has collaborated with esteemed colleagues, including Zhigang He and Vuk Koprivica. Together, they have contributed to a research environment that fosters innovation and seeks to solve complex neurological challenges.
Conclusion
Rajeev Sivasankaran stands out as a key figure in the realm of axon regeneration, with impactful patents that could transform treatment strategies for neurological injuries. His ongoing research efforts at the Children’s Medical Center Corporation showcase his dedication to enhancing the understanding and treatment of central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
